HSE approves new drug that can cut the chances of breast cancer recurring by over 30%
THE HEALTH SERVICE Executive has approved a new drug for people with breast cancer, which could cut the chances of the disease recurring by over 30%. Abemaciclib from US pharmaceutical company Eli Lilly and Company will be available to patients from June. …